Compare ADMA Biologics Inc (ADMA) vs Innodata Inc (INOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Innodata Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Innodata Inc trades at $63.03 (market cap $2.05B). The key difference: ADMA Biologics Inc and Innodata Inc are close in size by market cap, and Innodata Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | INOD | |
|---|---|---|
Market Cap | $2.22B | $2.05B |
Sector | Health | Technology |
52-Week High | $20.38 | $121.50 |
52-Week Low | $7.60 | $34.45 |
Enterprise Value | $2.29B | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →
